Stress-Induced Senescence of Human Umbilical Cord Mesenchymal Stromal Cells Caused by Mitomycin C.
Key claim: Mitomycin C induces DNA double-strand breaks and p53/p21/p27-mediated proliferation arrest in human umbilical cord MSCs without a classical senescent phenotype, reflecting high resistance of perinatal cells to aging.
Abstract
Studying stress-induced senescence of umbilical cord-derived mesenchymal stromal cells (UCMSCs) is important for ensuring the safety of their application in regenerative medicine. This study provides a comprehensive analysis of senescence features in UC-MSCs 7 days after treatment with mitomycin C (1.5 μg/mL). Despite the accumulation of DNA double-strand breaks (γH2AX/53BP1 foci) and complete proliferation arrest (the absence of Ki‑67cells and the loss of colony-forming ability) while maintaining viability, the cells did not acquire a classical senescent phenotype. Cell cycle arrest was mediated by activation of the p53/p21/p27 pathway without p16 involvement, and was accompanied by increased expression of SASP factors (IL‑8 and PAI‑1) and decreased levels of COL1A1 and SPARC, while SA-β-gal, oxidative stress, mitochondrial dysfunction, and lysosomal accumulation were absent. These findings indicate a unique response of UC-MSCs, namely, a p53-dependent proliferation arrest without full senescence, which reflects the high resistance of perinatal cells to aging.
Why this matters
The finding sharpens a distinction the senescence literature often blurs: DNA-damage-triggered p53/p21/p27 proliferation arrest is not the same as entry into a classical senescent state with SASP output. In perinatal human umbilical cord MSCs — a widely used cell-therapy substrate — a canonical DNA-crosslinker induces arrest without the secretory phenotype, suggesting developmental origin tunes how far along the senescence program a stressed cell travels.